Almanack Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $252K | Hold |
622
| – | – | 0.04% | 176 |
|
|
2025
Q1 | $310K | Sell |
622
-32
| -5% | -$15.9K | 0.06% | 112 |
|
|
2024
Q4 | $340K | Sell |
654
-270
| -29% | -$140K | 0.05% | 131 |
|
|
2024
Q3 | $572K | Buy |
924
+43
| +5% | +$26.6K | 0.09% | 101 |
|
|
2024
Q2 | $487K | Buy |
881
+5
| +0.6% | +$2.77K | 0.08% | 109 |
|
|
2024
Q1 | $509K | Buy |
876
+49
| +6% | +$28.5K | 0.09% | 102 |
|
|
2023
Q4 | $439K | Sell |
827
-15
| -2% | -$7.96K | 0.08% | 99 |
|
|
2023
Q3 | $426K | Sell |
842
-10
| -1% | -$5.06K | 0.08% | 95 |
|
|
2023
Q2 | $445K | Buy |
852
+13
| +2% | +$6.78K | 0.08% | 99 |
|
|
2023
Q1 | $484K | Hold |
839
| – | – | 0.1% | 89 |
|
|
2022
Q4 | $462K | Buy |
+839
| New | +$462K | 0.1% | 86 |
|
|
2022
Q3 | – | Sell |
-1,535
| Closed | -$834K | – | 932 |
|
|
2022
Q2 | $834K | Buy |
1,535
+280
| +22% | +$152K | 0.08% | 152 |
|
|
2022
Q1 | $742K | Sell |
1,255
-22
| -2% | -$13K | 0.06% | 191 |
|
|
2021
Q4 | $852K | Buy |
1,277
+211
| +20% | +$141K | 0.07% | 169 |
|
|
2021
Q3 | $609K | Buy |
1,066
+196
| +23% | +$112K | 0.05% | 220 |
|
|
2021
Q2 | $439K | Sell |
870
-188
| -18% | -$94.9K | 0.04% | 254 |
|
|
2021
Q1 | $483K | Sell |
1,058
-3
| -0.3% | -$1.37K | 0.05% | 243 |
|
|
2020
Q4 | $494K | Sell |
1,061
-41
| -4% | -$19.1K | 0.06% | 209 |
|
|
2020
Q3 | $516K | Buy |
+1,102
| New | +$516K | 0.06% | 201 |
|